Azobenzene

Azobenzene

SCHEMBL11878769

c1ccc(/N=N/c2ccccc2)cc1.c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 1.00
MEN1 O00255 5/20 0.67
KMT2A Q03164 5/20 0.67
MAPT P10636 5/20 0.67
NPC1 O15118 3/20 0.67
RAB9A P51151 3/20 0.67
PKM P14618 1/20 0.67
HTT P42858 1/20 0.67
TDP1 Q9NUW8 6/20 0.57
MAPK1 P28482 5/20 0.57
TSHR P16473 3/20 0.57
TRPA1 O75762 2/20 0.57
HSD17B10 Q99714 1/20 0.57
MAOA P21397 1/20 0.55
MAOB P27338 1/20 0.55
CYP1A1 P04798 1/20 0.52
CYP1B1 Q16678 1/20 0.52
CASP3 P42574 2/20 0.52
SENP8 Q96LD8 2/20 0.52
SENP7 Q9BQF6 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Azobenzene SCHEMBL6562161 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2AMAPTNPC1
Azobenzene SCHEMBL6703357 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2AMAPTNPC1
Azobenzene SCHEMBL32033 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2AMAPTNPC1
Azobenzene SCHEMBL565791 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2AMAPTNPC1
Azobenzene SCHEMBL32032 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2AMAPTNPC1
Azobenzene SCHEMBL28274947 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2AMAPTNPC1
Azobenzene SCHEMBL11124477 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2AMAPTNPC1
Azobenzene SCHEMBL188378 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2AMAPTNPC1
Azobenzene SCHEMBL22982916 0.96 ALDH1A1 (0.92) ALDH1A1MEN1KMT2AMAPTNPC1
SCHEMBL21024214 0.96 ALDH1A1 (0.92) ALDH1A1MEN1KMT2AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260018687-A1 SEPARATOR, SECONDARY BATTERY INCLUDING SEPARATOR, AND POWER CONSUMING APPARATUS CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) 2026-01-15 US disclosed
CN-111562729-B Light-responsive low-molecular material, adhesive, toner, and image forming method 柯尼卡美能达株式会社 2024-04-05 CN disclosed
CN-103987846-A Double-stranded nucleic acid, use and kit thereof in ribonuclease detection SUZHOU RIBO LIFE SCIENCE CO LTD 2014-08-13 CN disclosed
US-3971738-A Heavy metal complexes of azo compounds containing a halogeno-2,3-dihydroxy pyridine coupling component CIBA-GEIGY AG (CH) 1976-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260018687-A1 SEPARATOR, SECONDARY BATTERY INCLUDING SEPARATOR, AND POWER CONSUMING APPARATUS CTCF, EBP, AS3MT ALDH1A1 1624/4885MEN1 4422/4885KMT2A 410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.